Wrapmanager Inc Genmab A/S Transaction History

Wrapmanager Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$33.8 - $47.06 $171,467 - $238,735	5,073 New	5,073 $215,000
Q2 2022 Aug 05, 2022	SELL	$26.83 - $38.57 $181,290 - $260,617	-6,757 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$30.95 - $39.68 $49,179 - $63,051	1,589 Added 30.75%	6,757 $244,000
Q4 2021 Feb 07, 2022	SELL	$35.87 - $47.12 $72,529 - $95,276	-2,022 Reduced 28.12%	5,168 $204,000
Q3 2021 Nov 10, 2021	BUY	$41.55 - $48.72 $298,744 - $350,296	7,190 New	7,190 $314,000

236

52.5M

10.2K

25.5K

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

Get notified when there are updates to the investment portfolio of Wrapmanager Inc, based on Form 13F filings with the SEC.

Stay updated on Wrapmanager Inc with notifications on news.